Status:
RECRUITING
Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Cystic Fibrosis Foundation
Baylor College of Medicine
Conditions:
Cystic Fibrosis Pulmonary Exacerbation
Eligibility:
All Genders
6-25 years
Brief Summary
The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cy...
Detailed Description
This research is using continuous glucose monitoring (CGM) to study changes in blood sugar levels that may occur in youth with cystic fibrosis (CF) and cystic fibrosis related diabetes (CFRD) who expe...
Eligibility Criteria
Inclusion
- 6- 25 years old
- Confirmed diagnosis of cystic fibrosis (based on sweat chloride and/or two known disease causing CF mutations)
- access to a smart phone and/or internet connection and the ability to complete remote telehealth visits
Exclusion
- known type 1 or type 2 diabetes, monogenic diabetes
- critical illness requiring admission to the ICU
- pregnancy
Key Trial Info
Start Date :
February 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06546943
Start Date
February 4 2022
End Date
October 31 2025
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado, University of Colorado Denver
Aurora, Colorado, United States, 80045